Jitendra Pandurang Suryavanshi
About Jitendra Pandurang Suryavanshi
Data last updated:
Jitendra Pandurang Suryavanshi is a Director at Lysca Pharmaceuticals Private Limited (since 2021). The company operates in Pharma. Lysca Pharmaceuticals Private Limited reported revenue of ₹1.08 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Lysca Pharmaceuticals Private Limited U24230MH2020PTC339574 | Director | 24 Dec 2021 | 2020 | ₹1.08 Cr (FY 2024) | Active |
Board colleagues of Jitendra Pandurang Suryavanshi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bimal Naresh Patel | 08771813 | Lysca Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jitendra Pandurang Suryavanshi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jitendra Pandurang Suryavanshi
Jitendra Pandurang Suryavanshi currently holds 1 directorship: Lysca Pharmaceuticals Private Limited (Director, since 24 Dec 2021, revenue ₹1.08 Cr (FY 2024)).
Jitendra Pandurang Suryavanshi was first appointed on 24 Dec 2021 as Director at Lysca Pharmaceuticals Private Limited.
The current boards of Jitendra Pandurang Suryavanshi's companies include Bimal Naresh Patel (Lysca Pharmaceuticals Private Limited).